- Home
- RLAY vs TECH Comparison
RLAY vs TECH Comparison
Compare RLAY & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- TECH
- Stock Information
- Founded
- RLAY 2015
- TECH 1976
- Country
- RLAY United States
- TECH United States
- Employees
- RLAY N/A
- TECH N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RLAY Health Care
- TECH Health Care
- Exchange
- RLAY Nasdaq
- TECH Nasdaq
- Market Cap
- RLAY N/A
- TECH 8.0B
- IPO Year
- RLAY 2020
- TECH 1989
- Fundamental
- Price
- RLAY $2.69
- TECH $48.10
- Analyst Decision
- RLAY Strong Buy
- TECH Buy
- Analyst Count
- RLAY 10
- TECH 9
- Target Price
- RLAY $19.33
- TECH $81.25
- AVG Volume (30 Days)
- RLAY 3.0M
- TECH 2.2M
- Earning Date
- RLAY 05-01-2025
- TECH 05-07-2025
- Dividend Yield
- RLAY N/A
- TECH 0.63%
- EPS Growth
- RLAY N/A
- TECH N/A
- EPS
- RLAY N/A
- TECH 0.98
- Revenue
- RLAY $10,007,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- RLAY N/A
- TECH $8.19
- Revenue Next Year
- RLAY $420.18
- TECH $8.85
- P/E Ratio
- RLAY N/A
- TECH $52.13
- Revenue Growth
- RLAY N/A
- TECH 4.46
- 52 Week Low
- RLAY $1.78
- TECH $46.44
- 52 Week High
- RLAY $10.72
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- RLAY 48.08
- TECH 33.97
- Support Level
- RLAY $1.82
- TECH $46.44
- Resistance Level
- RLAY $2.81
- TECH $53.00
- Average True Range (ATR)
- RLAY 0.26
- TECH 3.30
- MACD
- RLAY 0.09
- TECH -0.27
- Stochastic Oscillator
- RLAY 88.41
- TECH 13.00
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.